{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:05:21Z","timestamp":1792699521982,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00345-015-1695-0","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T06:28:54Z","timestamp":1443248934000},"page":"853-857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG)"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1710-125X","authenticated-orcid":false,"given":"Konstantinos","family":"Koutsoukos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Tzannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Karavasilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Bakoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Makatsoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. N.","family":"Papandreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Pectasides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotelis","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"key":"1695_CR1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","volume":"17","author":"SD Fossa","year":"1999","unstructured":"Fossa SD, Horwich A, Russell JM et al (1999) Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomised trial. J Clin Oncol 17:1146\u20131154","journal-title":"J Clin Oncol"},{"key":"1695_CR2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/annonc\/mdh301","volume":"15","author":"HJ Schmoll","year":"2004","unstructured":"Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377\u20131399","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"1695_CR3","doi-asserted-by":"crossref","first-page":"v140","DOI":"10.1093\/annonc\/mdq176","volume":"21","author":"HJ Schmoll","year":"2010","unstructured":"Schmoll HJ, Jordan K, Huddart R, ESMO Guidelines Working Group et al (2010) Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v140\u2013v146. doi: 10.1093\/annonc\/mdq176","journal-title":"Ann Oncol"},{"key":"1695_CR4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.urolonc.2005.06.003","volume":"23","author":"BS Carver","year":"2005","unstructured":"Carver BS, Motzer RJ, Kondagunta GV et al (2005) Late relapse of testicular germ cell tumors. Urol Oncol 23:441\u2013445","journal-title":"Urol Oncol"},{"key":"1695_CR5","unstructured":"NCCN (2011) Clinical practice guidelines in oncology: testicular cancer. Version 2.2011. www.nccn.org\/professionals\/physician_gls\/pdf\/testicular.pdf . Accessed 10 Oct 2012"},{"issue":"36","key":"1695_CR6","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1200\/JCO.2005.01.4092","volume":"23","author":"J Nuver","year":"2005","unstructured":"Nuver J, Smit AJ, van der Meer J et al (2005) Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23(36):9130\u20139137","journal-title":"J Clin Oncol"},{"issue":"18","key":"1695_CR7","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB, Foss\u00e5 SD, Schonfeld SJ et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97(18):1354\u20131365","journal-title":"J Natl Cancer Inst"},{"issue":"30","key":"1695_CR8","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","volume":"30","author":"HS Haugnes","year":"2012","unstructured":"Haugnes HS, Bosl GJ, Boer H et al (2012) Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 30(30):3752\u20133763","journal-title":"J Clin Oncol"},{"key":"1695_CR9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","volume":"23","author":"WG Jones","year":"2005","unstructured":"Jones WG, Foss\u00e5 SD, Mead GM et al (2005) Randomized trial of 30 versus 20\u00a0Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23:1200\u20131208","journal-title":"J Clin Oncol"},{"key":"1695_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","volume":"366","author":"RT Oliver","year":"2005","unstructured":"Oliver RT, Mason MD, Mead GM et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293\u2013300","journal-title":"Lancet"},{"key":"1695_CR11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/annonc\/mdg241","volume":"14","author":"J Aparicio","year":"2003","unstructured":"Aparicio J, Garcia del Muro X, Maroto P et al (2003) Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 14:867\u2013872","journal-title":"Ann Oncol"},{"key":"1695_CR12","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","volume":"357","author":"DJ Brenner","year":"2007","unstructured":"Brenner DJ, Hall EJ (2007) Computed tomography: an increasing source of radiation exposure. N Engl J Med 357:2277\u20132284","journal-title":"N Engl J Med"},{"key":"1695_CR13","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1200\/JCO.2011.34.6379","volume":"29","author":"C Walraven van","year":"2011","unstructured":"van Walraven C, Fergusson D, Earle C et al (2011) Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. J Clin Oncol 29:2883\u20132888","journal-title":"J Clin Oncol"},{"key":"1695_CR14","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"P Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A et al (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20:4448\u20134452","journal-title":"J Clin Oncol"},{"key":"1695_CR15","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","volume":"23","author":"J Aparicio","year":"2005","unstructured":"Aparicio J, Germ\u00e0 JR, Garc\u00eda del Muro X et al (2005) Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23:8717\u20138723","journal-title":"J Clin Oncol"},{"key":"1695_CR16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.urology.2007.07.016","volume":"70","author":"A Bamias","year":"2007","unstructured":"Bamias A, Aravantinos G, Deliveliotis C et al (2007) Two cycles of etoposide\/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology Group. Urology 70:1179\u20131183","journal-title":"Urology"},{"issue":"Suppl 2","key":"1695_CR17","first-page":"72","volume":"19","author":"A Horwich","year":"1992","unstructured":"Horwich A, Mason M, Dearnaley DP (1992) Use of carboplatin in germ cell tumors of the testis. Semin Oncol 19(Suppl 2):72\u201377","journal-title":"Semin Oncol"},{"issue":"1","key":"1695_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01203075","volume":"122","author":"KP Dieckmann","year":"1996","unstructured":"Dieckmann KP, Krain J, K\u00fcster J, Br\u00fcggeboes B (1996) Adjuvant carboplatin treatment for seminoma clinical stage I. J Cancer Res Clin Oncol 122(1):63\u201366","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1695_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31\u201341","journal-title":"Nephron"},{"key":"1695_CR20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","volume":"29","author":"RT Oliver","year":"2011","unstructured":"Oliver RT, Mead GM, Rustin GJ et al (2011) Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 29:957\u2013962","journal-title":"J Clin Oncol"},{"key":"1695_CR21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","volume":"17","author":"SD Fossa","year":"1999","unstructured":"Fossa SD, Horwich A, Russell JM et al (1999) Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 17:1146\u20131154","journal-title":"J Clin Oncol"},{"key":"1695_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/andr.280","volume":"3","author":"G Cohn-Cedermark","year":"2015","unstructured":"Cohn-Cedermark G, Stahl O, Tandstad T, SWENOTECA (2015) Surveillance vs. adjuvant therapy of clinical stage I testicular tumors\u2014a review and the SWENOTECA Experience. Andrology 3:102\u2013110","journal-title":"Andrology"},{"key":"1695_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","volume":"22","author":"C Kollmannsberger","year":"2015","unstructured":"Kollmannsberger C, Tandstad T, Philippe L, Bedard P, Cohn-Cedermark G et al (2015) Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol 22:51\u201357","journal-title":"J Clin Oncol"},{"issue":"1","key":"1695_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0090-4295(99)00376-3","volume":"55","author":"KP Dieckmann","year":"2000","unstructured":"Dieckmann KP, Br\u00fcggeboes B et al (2000) Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient? Urology 55(1):102\u2013106","journal-title":"Urology"},{"key":"1695_CR25","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2011.36.0503","volume":"29","author":"J Aparicio","year":"2011","unstructured":"Aparicio J, Maroto P, Garc\u00eda del Muro X et al (2011) Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study. J Clin Oncol 29:4677\u20134681","journal-title":"J Clin Oncol"},{"issue":"7","key":"1695_CR26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1464-410X.2010.09658.x","volume":"107","author":"H Steiner","year":"2011","unstructured":"Steiner H, Scheiber K, Berger AP et al (2011) Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma. BJU Int 107(7):1074\u20131079","journal-title":"BJU Int"},{"issue":"Supplement 6","key":"1695_CR27","doi-asserted-by":"crossref","first-page":"vi125","DOI":"10.1093\/annonc\/mdt304","volume":"24","author":"J Oldenburg","year":"2013","unstructured":"Oldenburg J, Foss\u00e5 SD, Nuver J (2013) Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Supplement 6):vi125\u2013vi132","journal-title":"Ann Oncol"},{"key":"1695_CR28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eururo.2011.05.038","volume":"60","author":"P Albers","year":"2011","unstructured":"Albers P, Albrecht W, Algaba F et al (2011) EAU guidelines on testicular cancer: 2011 update. Eur Urol 60:304\u2013319","journal-title":"Eur Urol"},{"key":"1695_CR29","unstructured":"National Comprehensive Cancer Network NCCN (2012) Clinical Practice Guidelines in Oncology for Testicular Cancer, NCCN. http:\/\/www.nccn.org (Version 1.2015)"},{"issue":"25","key":"1695_CR30","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/annonc\/mdu437","volume":"2014","author":"J Aparicio","year":"2014","unstructured":"Aparicio J, Maroto P et al (2014) Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). Ann Oncol 2014(25):2173\u20132178","journal-title":"Ann Oncol"},{"issue":"1","key":"1695_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","volume":"4","author":"P Chung","year":"2015","unstructured":"Chung P, Daugaard G, Tyldesley S et al (2015) Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance. Cancer Med 4(1):155\u2013160","journal-title":"Cancer Med"},{"key":"1695_CR32","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0022-5347(01)64839-0","volume":"157","author":"P Warde","year":"1997","unstructured":"Warde P, Gospodarowicz M, Banerjee D et al (1997) Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 157:1705\u20131709","journal-title":"J Urol"},{"issue":"3","key":"1695_CR33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ctrv.2009.12.011","volume":"36","author":"K Pliarchopoulou","year":"2010","unstructured":"Pliarchopoulou K, Pectasides D (2010) Late complications of chemotherapy in testicular cancer. Cancer Treat Rev 36(3):262\u2013267. doi: 10.1016\/j.ctrv.2009.12.011","journal-title":"Cancer Treat Rev"},{"key":"1695_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/annonc\/mdm540","volume":"19","author":"T Powles","year":"2008","unstructured":"Powles T, Robinson D, Shamash J et al (2008) The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 19:443\u2013444","journal-title":"Ann Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-015-1695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-015-1695-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-015-1695-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T20:57:20Z","timestamp":1599598640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-015-1695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1007\/s00345-015-1695-0","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,26]]}}}